Havana, May 4 (Prensa Latina) The authorization for the Cuban-made injectable drug Heberprot-P to begin phase three of clinical trials in the United States is a new achievement by Cuban scientists and researchers from the biotechnological and pharmaceutical industry. The post Cuban drug Heberprot-P authorized for medical trials in the US first appeared on Prensa Latina. Read this story
